CD20 [L26]
$295.00 – $1,661.00
Description
Product Description
CD20 antibody [L26] reacts with a protein of a 30-33 kDa polypeptide present in B-cells. L26 has been shown to react with the majority of B-cells present in peripheral blood and lymphoid tissues. In normal lymphoid tissue, CD20 [L26] marks B-cells in germinal centers, particularly immunoblasts. This CD20 antibody has been shown to be a reliable pan B-cell marker. Studies also show CD20 [L26] marking diffuse large B-cell lymphomas. CD20 [L26] rarely marks T-cells.
Specifications
Specifications
| Intended Use | |
|---|---|
| Species Reactivity | |
| Source | |
| Clone | |
| Isotype | |
| Antigen | |
| Localization | |
| Positive Control |
Datasheets & SDS
| Download Data Sheet |
| Download RUO Data Sheet for International |
| Download SDS Sheet |
Regulatory Notice: Biocare’s IVD-labeled products comply with US-FDA and European IVDD regulation. Other regions may have additional requirements for such labeling, please contact your local distributor.
References
1. Kitamura A, et al. Histopathology. 2005 Nov; 47(5):523-32.
2. Tao K, et al. Zhonghua Bing Li Xue Za Zhi. 2002 Apr; 31(2):112-5.
3. Chen CC, et al. Appl Immunohistochem Mol Morphol. 2000 Mar; 8(1):1-11.
Reviews (0)
Be the first to review “CD20 [L26]”
You must be logged in to post a review.
Related products
B
![(L) Anaplastic large cell lymphoma and (R) Lung adenocarcinoma stained with ALK antibody [5A4]](https://biocare.net/wp-content/uploads/3041-247x296.jpg)
Reviews
There are no reviews yet.